Pata Ramakanth, Dolkar Tsering, Patel Meet, Nway Nway
Pulmonary and Critical Care Medicine, One Brooklyn Health, New York, USA.
Pulmonary and Critical Care Medicine, University of Cincinnati Medical Center, Cincinnati, USA.
Cureus. 2021 Dec 2;13(12):e20115. doi: 10.7759/cureus.20115. eCollection 2021 Dec.
Drug-induced liver injury (DILI) is the most common cause of acute liver failure in the United States. Clinical presentation of drug-induced liver injury may vary from asymptomatic or subtle symptoms to encephalopathy with serious morbidity. Early discontinuation of the offending agent is important to prevent clinical deterioration. Occasionally, despite discontinuation, there may be worsening of liver failure with grim prognosis as we present in this case report. Here, we report a case of a 61-year-old lady with a past medical history of sarcoidosis, stage IV and severe pulmonary hypertension initially admitted for the management of COVID pneumonia. Her hospitalization was complicated by fungemia with Aspergillus for which voriconazole was initiated, and two weeks into the course, acute liver injury diagnosed was most probably related to voriconazole. Despite discontinuation, her condition deteriorated, eventually culminating in mortality.
药物性肝损伤(DILI)是美国急性肝衰竭最常见的病因。药物性肝损伤的临床表现可能从无症状或轻微症状到伴有严重发病率的脑病不等。早期停用致病药物对于预防临床恶化很重要。偶尔,尽管停用了药物,但肝衰竭仍可能恶化,预后严峻,正如我们在本病例报告中所呈现的那样。在此,我们报告一例61岁女性病例,她既往有结节病病史,处于IV期且患有严重肺动脉高压,最初因新冠肺炎入院治疗。她的住院治疗因曲霉菌血症而复杂化,为此开始使用伏立康唑,在治疗过程的两周后,诊断出的急性肝损伤很可能与伏立康唑有关。尽管停用了药物,她的病情仍恶化,最终导致死亡。